Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Pyridyl amides as potent inhibitors of T-type calcium channels.

Reger TS, Yang ZQ, Schlegel KA, Shu Y, Mattern C, Cube R, Rittle KE, McGaughey GB, Hartman GD, Tang C, Ballard J, Kuo Y, Prueksaritanont T, Nuss CE, Doran SM, Fox SV, Garson SL, Li Y, Kraus RL, Uebele VN, Renger JJ, Barrow JC.

Bioorg Med Chem Lett. 2011 Mar 15;21(6):1692-6. doi: 10.1016/j.bmcl.2011.01.089. Epub 2011 Jan 26.

PMID:
21316226
2.

T-type calcium channels inhibitors: a patent review.

Giordanetto F, Knerr L, Wållberg A.

Expert Opin Ther Pat. 2011 Jan;21(1):85-101. doi: 10.1517/13543776.2011.536532. Epub 2010 Nov 19. Review.

PMID:
21087200
3.

Pathophysiological significance of T-type Ca2+ channels: T-type Ca2+ channels and drug development.

Tanaka H, Shigenobu K.

J Pharmacol Sci. 2005 Nov;99(3):214-20. Review.

4.

Pharmacology of recombinant low-voltage activated calcium channels.

Lacinov√° L.

Curr Drug Targets CNS Neurol Disord. 2004 Apr;3(2):105-11. Review.

PMID:
15078185
5.

The role of T-type calcium channels in epilepsy and pain.

Nelson MT, Todorovic SM, Perez-Reyes E.

Curr Pharm Des. 2006;12(18):2189-97. Review.

PMID:
16787249
6.

Ca2+ channel subtypes and pharmacology in the kidney.

Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T.

Circ Res. 2007 Feb 16;100(3):342-53. Review.

7.

Molecular pharmacology of T-type Ca2+ channels.

Heady TN, Gomora JC, Macdonald TL, Perez-Reyes E.

Jpn J Pharmacol. 2001 Apr;85(4):339-50. Review.

8.

T-type Ca2+ channels as therapeutic targets in the nervous system.

Shin HS, Cheong EJ, Choi S, Lee J, Na HS.

Curr Opin Pharmacol. 2008 Feb;8(1):33-41. doi: 10.1016/j.coph.2007.12.003. Epub 2008 Jan 18. Review.

PMID:
18203662
9.

Towards the discovery of novel T-type calcium channel blockers.

Lory P, Chemin J.

Expert Opin Ther Targets. 2007 May;11(5):717-22. Review.

PMID:
17465728
10.

Linking calcium-channel isoforms to potential therapies.

Belardetti F, Zamponi GW.

Curr Opin Investig Drugs. 2008 Jul;9(7):707-15. Review.

PMID:
18600576
11.

Calcium antagonists: Do they equally protect against kidney injury?

Hart P, Bakris GL.

Kidney Int. 2008 Apr;73(7):795-6. doi: 10.1038/sj.ki.5002773. Review.

Supplemental Content

Support Center